Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients...
Main Authors: | Despoina-Rafailia Benetou, Charalampos Varlamos, Christos Pappas, Fotios Kolokathis, Dimitrios Alexopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-10-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2020.30 |
Similar Items
-
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020-11-01) -
Antithrombotic Therapy in Complex Percutaneous Coronary Intervention Patients Requiring Chronic Anticoagulation
by: Despoina-Rafailia Benetou, et al.
Published: (2021-05-01) -
Left Main Disease and Bifurcation Percutaneous Coronary Intervention: Focus on Antithrombotic Therapy
by: Charalampos Varlamos, et al.
Published: (2021-06-01) -
Antithrombotic Therapy in Chronic Total Occlusion Interventions
by: Iosif Xenogiannis, et al.
Published: (2021-05-01) -
Delayed percutaneous coronary intervention for an extensive iatrogenic left main coronary artery dissection: a case report
by: Charalampos Varlamos, et al.
Published: (2022-12-01)